'Nevada Senators Take Up Resolution Calling On Congress To Reschedule Psychedelics And Streamline Research' - Marijuana Moment

BenzingaMar 12 11:45 ET

Bright Minds Biosciences Expands Scientific Advisory Board

TipRanksMar 4 08:21 ET

Express News | Bright Minds Biosciences Expands Scientific Advisory Board to Include Renowned Leaders in Epilepsy Research

ReutersMar 4 08:00 ET

Bright Minds Biosciences to Participate at Three Healthcare Conferences in March

GlobeNewswireFeb 24 06:50 ET

Bright Minds Biosciences Analyst Ratings

BenzingaFeb 19 11:25 ET · Ratings

H.C. Wainwright Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $85

Moomoo NewsFeb 19 10:31 ET · Ratings

Bright Minds Biosciences' BMB-101: A Promising Contender in Serotonergic Epilepsy Treatment With Strong Market Potential

TipRanksFeb 19 09:35 ET

Bright Minds Biosciences | 6-K: Report of foreign private issuer (related to financial reporting)

SECFeb 14 12:21 ET · Announcements

Bright Minds Biosciences Shows Financial Improvement in Latest Report

TipRanksFeb 14 06:31 ET

Express News | Bright Minds Biosciences 13G Filing Shows Janus Henderson Group Reported A 11.6% Stake In The Co As Of January 31, 2025

BenzingaFeb 7 10:59 ET

Express News | Bright Minds Biosciences Inc Files for Offering of up to 1.6 Mln Common Shares by the Selling Securityholders - SEC Filing

ReutersFeb 5 06:10 ET

HHS Secretary Nominee RFK Jr. Faces Contentious Senate Hearing

Seeking AlphaJan 29 15:54 ET

This Prudential Financial Analyst Begins Coverage On A Bearish Note; Here Are Top 5 Initiations For Thursday

BenzingaJan 23 07:34 ET

Piper Sandler Maintains Bright Minds Biosciences(DRUG.US) With Buy Rating, Maintains Target Price $93

Moomoo NewsJan 23 07:31 ET · Ratings

Bright Minds Biosciences Initiated at Overweight by Piper Sandler

Dow JonesJan 23 07:11 ET · Ratings

Piper Sandler Initiates Bright Minds Biosciences(DRUG.US) With Buy Rating, Announces Target Price $93

Moomoo NewsJan 23 05:34 ET · Ratings

Yasmeen Rahimi's Buy Rating on Bright Minds Biosciences Driven by Promising Potential of BMB-101 for Epilepsy Treatment

TipRanksJan 23 05:16 ET

Psychedelic Drug Developer Lykos Could Get Lifeline From Former Tesla Board Member

Seeking AlphaJan 10 13:27 ET

Cantor Fitzgerald Initiates Bright Minds Biosciences(DRUG.US) With Buy Rating

Moomoo NewsJan 10 09:31 ET · Ratings

Cantor Fitzgerald Initiates Bright Minds Biosciences With Overweight Rating

MT NewswiresJan 10 09:03 ET